Two widely touted Alzheimer’s drugs have been shown to enable patients to remain in their homes for longer periods of time.

With early diagnosis of Alzheimer's disease comes the possibility of treatment to not only help manage symptoms but also slow ...

"By activating microglia generally, our antibody can remove amyloid beta plaques in mice, and it could potentially clear other damaging proteins in other neurodegenerative diseases, including ...

Lecanemab has given us more years together. That’s not ‘minute’ nor ‘minimal’ to me,” writes one reader in STAT’s letters to ...

WashU Medicine-led trial evaluating investigational drug from Eli Lilly and Company aims to stop disease before symptoms ...

Brain inflammation, while a crucial part of the body's immune response, takes on a detrimental role in Alzheimer's disease.

The factor that tips you over the edge from being at risk for a disease to actually developing the disease is not always ...

An international clinical trial aimed at preventing Alzheimer’s disease (AD) in young adults who are at risk of developing the neurodegenerative disorder has begun.